Subscribe To
ZURA / ZURA Stock Alert: Zura Bio SPAC Merger Rally Ends
ZURA News
By The Motley Fool
June 20, 2023
Why Shares of Zura Bio Climbed Tuesday
Zura Bio's lead therapy is ZB-106. The company plans to start two phase 2 trials for the therapy. more_horizontal
By InvestorPlace
March 23, 2023
ZURA Stock Alert: Zura Bio SPAC Merger Rally Ends
Zura Bio (NASDAQ: ZURA ) stock is on the move Thursday following the clinical-stage biotechnology company's recent public debut. Zura Bio went public more_horizontal